$WST

AI 分析

生成於 May 11, 2026

AI Score
72/ 100
Hold$WST

West Pharmaceutical Services

$WSTNYSEHealthcareLarge-Cap

West designs and manufactures injectable drug delivery systems including stoppers, seals, and containment components.

Market Cap
$25.0B
Revenue (TTM)
$2.9B
+2.0%
Net Income (TTM)
$0.5B
+5.0%
EPS (TTM)
$6.80
P/E Ratio
35.0
Dividend Yield
0.2%
52-Week Range
$300-$440
Beta
0.82
Dimension Scores
Fundamental
74
Technical
66
Sentiment
70
Risk / Reward
74
Momentum
66
FundTechSentRiskMome
Financial Health
Profitability
79strong
Growth
69moderate
Liquidity
82strong
Solvency
76strong
Efficiency
72strong

Valuation, technical analysis, investment thesis, risk assessment and more for $WST

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。